Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F N E Gavins

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Thescientificworldjournal|August 29, 2006
Annexin 1 and melanocortin peptide therapy for protection against ischaemic-reperfusion damage in the heartF N E Gavins, G Leoni, S J Getting
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 29, 2005
A twist in anti-inflammation: annexin 1 acts via the lipoxin A4 receptorF N E Gavins, P Sawmynaden, B E Chatterjee, et al.
Journal of Thrombosis and Haemostasis : JTH|December 21, 2010
Microvascular thrombosis and CD40/CD40L signalingF N E Gavins, G Li, J Russell, et al.
Stem Cell Research|April 2, 2019
Potential therapeutic roles of stem cells in ischemia-reperfusion injuryM Barzegar, G Kaur, F N E Gavins, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|January 9, 2003
The annexin-1 knockout mouse: what it tells us about the inflammatory responseF Roviezzo, S J Getting, M J Paul-Clark, et al.
British Journal of Pharmacology|May 20, 2015
IL-1β reduces tonic contraction of mesenteric lymphatic muscle cells, with the involvement of cycloxygenase-2 and prostaglandin E2M Al-Kofahi, F Becker, F N E Gavins, et al.
Pathophysiology : the Official Journal of the International Society for Pathophysiology|July 15, 2019
Dynamic gut microbiome changes following regional intestinal lymphatic obstruction in primatesF Becker, F N E Gavins, J Fontenot, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Thescientificworldjournal|August 29, 2006
Annexin 1 and melanocortin peptide therapy for protection against ischaemic-reperfusion damage in the heartF N E Gavins, G Leoni, S J Getting
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 29, 2005
A twist in anti-inflammation: annexin 1 acts via the lipoxin A4 receptorF N E Gavins, P Sawmynaden, B E Chatterjee, et al.
Journal of Thrombosis and Haemostasis : JTH|December 21, 2010
Microvascular thrombosis and CD40/CD40L signalingF N E Gavins, G Li, J Russell, et al.
Stem Cell Research|April 2, 2019
Potential therapeutic roles of stem cells in ischemia-reperfusion injuryM Barzegar, G Kaur, F N E Gavins, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|January 9, 2003
The annexin-1 knockout mouse: what it tells us about the inflammatory responseF Roviezzo, S J Getting, M J Paul-Clark, et al.
British Journal of Pharmacology|May 20, 2015
IL-1β reduces tonic contraction of mesenteric lymphatic muscle cells, with the involvement of cycloxygenase-2 and prostaglandin E2M Al-Kofahi, F Becker, F N E Gavins, et al.
Pathophysiology : the Official Journal of the International Society for Pathophysiology|July 15, 2019
Dynamic gut microbiome changes following regional intestinal lymphatic obstruction in primatesF Becker, F N E Gavins, J Fontenot, et al.
Pageof 1